Batmyagmar Jargalbat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Batmyagmar Jargalbat has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Enkhtsetseg Vanchinbazar
National Cancer Center of Mongolia, Ulaanbaatar, Mongolia
2 shared publications - Gonchigdorj Khuukhenkhuu
National University of Mongolia, Ulaanbaatar, Mongolia
2 shared publications - Odgerel Oidovsambuu
School of Engineering and Technology, National University of Mongolia, Ulaanbaatar 14201, Mongolia
2 shared publications - Suren Davaa
National University of Mongolia, Ulaanbaatar, Mongolia
2 shared publications - Undrakh Unenbat
National University of Mongolia, Ulaanbaatar, Mongolia
2 shared publications AL-FARABI KAZAKH NATIONAL UNIVERSITY
1 shared publication
Latest Publications
- Open Access
- 16 December 2025
- Published by al-Farabi Kazakh National University in International Journal of Mathematics and Physics
- Vol. 16 (2)
Response of Liver and Gastric Cancer Cells to Electron and X-ray Radiation
Radiotherapy remains a critical pillar of cancer treatment worldwide. This study evaluates the in vitro efficacy of high-energy ionizing radiation, specifically 6 MV electrons and 12 MV X-rays, generated by a Varian Clinac iX linear accelerator (linac), on human HepG2 (liver) and AGS (gastric) cell lines. Cell samples (1 ml) were irradiated with doses ranging from 0.5 Gy to 4 Gy. Cell viability was assessed using the WST assay 4-5 hours post-irradiation. The measured survival rates were critically compared with those predicted using the established linear-quadratic (LQ) model. The results revealed significant and consistent discrepancies between the experimental measurements and the theoretical predictions for both cell lines. For HepG2 cells, the measured survival rate at 4 Gy was higher than the predicted rate. Interestingly, AGS cells irradiated with 12 MV X-rays exhibited minimal cytotoxicity, with a viability rate of 99.0% at 3 Gy versus a predicted rate of 73.6%. These findings suggest a discrepancy between theoretical predictions and the short-term biological responses observed under the shallow in vitro irradiation conditions employed in this study. While the present study was not designed to isolate the underlying mechanisms, the results imply that factors inherent to high-energy beam delivery in thin in vitro geometries, together with the early (four to five hour) post-irradiation assessment window, may have contributed to the limited cytotoxicity observed in both cell lines. Further studies employing extended observation periods or complementary assays would be valuable in clarifying the temporal progression of MV-beam-induced cellular effects. Keywords: Varian Clinac iX, high-energy radiation, HepG2, AGS, cell viability, WST assay, Monitor Unit (MU).
- 16 December 2025
- Published by al-Farabi Kazakh National University in International Journal of Mathematics and Physics
- Vol. 16 (2)
Open AccessResponse of Liver and Gastric Cancer Cells to Electron and X-ray Radiation
Radiotherapy remains a critical pillar of cancer treatment worldwide. This study evaluates the in vitro efficacy of high-energy ionizing radiation, specifically 6 MV electrons and 12 MV X-rays, generated by a Varian Clinac iX linear accelerator (linac), on human HepG2 (liver) and AGS (gastric) cell lines. Cell samples (1 ml) were irradiated with doses ranging from 0.5 Gy to 4 Gy. Cell viability was assessed using the WST assay 4-5 hours post-irradiation. The measured survival rates were critically compared with those predicted using the established linear-quadratic (LQ) model. The results revealed significant and consistent discrepancies between the experimental measurements and the theoretical predictions for both cell lines. For HepG2 cells, the measured survival rate at 4 Gy was higher than the predicted rate. Interestingly, AGS cells irradiated with 12 MV X-rays exhibited minimal cytotoxicity, with a viability rate of 99.0% at 3 Gy versus a predicted rate of 73.6%. These findings suggest a discrepancy between theoretical predictions and the short-term biological responses observed under the shallow in vitro irradiation conditions employed in this study. While the present study was not designed to isolate the underlying mechanisms, the results imply that factors inherent to high-energy beam delivery in thin in vitro geometries, together with the early (four to five hour) post-irradiation assessment window, may have contributed to the limited cytotoxicity observed in both cell lines. Further studies employing extended observation periods or complementary assays would be valuable in clarifying the temporal progression of MV-beam-induced cellular effects. Keywords: Varian Clinac iX, high-energy radiation, HepG2, AGS, cell viability, WST assay, Monitor Unit (MU).
- Open Access
- 1 January 2024
- Published by al-Farabi Kazakh National University in International Journal of Mathematics and Physics
- Vol. 15 (2) , 42-48
Effects of gamma radiation on lung and colon cancer cell viability
In Mongolia, cancer treatment is carried out through radiation, chemotherapy and surgery, and there is only one state hospital that specializes in this field, the National Cancer Center of Mongolia. As our country's population has grown in recent years, data for 2023 from the Central Statistical Office show that the incidence of cancer, on the one hand, and the number of cases of the disease, on the other, are increasing as patients get younger. This study concerns an important part of the triad of cancer treatment, namely the evaluation of the efficacy of radiotherapy in an "in vitro" situation. Ionizing radiation has been shown to have a number of biological effects, including damage to DNA. This damage can manifest as double-strand breaks (DSB), base damage and single-strand breaks (SSB). The 60Co radiation source "Bhabhatron", which is installed at the National Cancer Center of Mongolia, is used as a gamma source for the cell viability experiment. In this experiment, we use two different cancer cell samples (A549, HCT116) and all used samples prepared in the Gene Engineering Laboratory of the National University of Mongolia in a quantity of 1 ml, and the cell samples were irradiated with doses of 2 Gy, 4 Gy, 6 Gy and 8 Gy. The cell viability of A549 and HCT116 cancer cells after gamma irradiation was determined using the WST assay and calculated using an analytical formula. The calculated and measured results are comparable for two different cancer cells.
- 1 January 2024
- Published by al-Farabi Kazakh National University in International Journal of Mathematics and Physics
- Vol. 15 (2) , 42-48
Open AccessEffects of gamma radiation on lung and colon cancer cell viability
In Mongolia, cancer treatment is carried out through radiation, chemotherapy and surgery, and there is only one state hospital that specializes in this field, the National Cancer Center of Mongolia. As our country's population has grown in recent years, data for 2023 from the Central Statistical Office show that the incidence of cancer, on the one hand, and the number of cases of the disease, on the other, are increasing as patients get younger. This study concerns an important part of the triad of cancer treatment, namely the evaluation of the efficacy of radiotherapy in an "in vitro" situation. Ionizing radiation has been shown to have a number of biological effects, including damage to DNA. This damage can manifest as double-strand breaks (DSB), base damage and single-strand breaks (SSB). The 60Co radiation source "Bhabhatron", which is installed at the National Cancer Center of Mongolia, is used as a gamma source for the cell viability experiment. In this experiment, we use two different cancer cell samples (A549, HCT116) and all used samples prepared in the Gene Engineering Laboratory of the National University of Mongolia in a quantity of 1 ml, and the cell samples were irradiated with doses of 2 Gy, 4 Gy, 6 Gy and 8 Gy. The cell viability of A549 and HCT116 cancer cells after gamma irradiation was determined using the WST assay and calculated using an analytical formula. The calculated and measured results are comparable for two different cancer cells.